During the H1N1 swine flu pandemic, much criticism was leveled at World Health Organization officials, accusing their response of being too heavily influenced by the pharmaceutical industry. But according to a panel of indepen…
The company has landed a lucrative flu-vaccine contract with the U.S. government. It’s worth $97 million over the first three years, and it can be extended for an additional two years, for a total contract value of $179.1 milli…
The pharmaceutical industry is ready to fall off a cliff — a “patent cliff.” Over the next few years, some of the world’s most popular and lucrative medicines will go off patent, and generic competition will siphon an estimate…
Pharmaceutical companies looking for fresh sources of profit are increasingly investing in a range of health care innovations that aren’t drugs at all, from smartphone apps and educational websites to social media platforms and…
Pfizer’s cancer drug Sutent and Novartis’s drug Afinitor have both been found to be effective against the rare form of pancreatic cancer that Apple CEO Steve Jobs was diagnosed with in 2004, according to two studies published i…